Phase 3 Herniorrhaphy Study for Postoperative Analgesia (EPOCH 2)
Status:
Completed
Trial end date:
2018-01-16
Target enrollment:
Participant gender:
Summary
This is a Phase 3, randomized, double-blind, saline placebo- and active-controlled,
multicenter study to evaluate the analgesic efficacy and safety of HTX 011 administered via
local administration into the surgical site in subjects undergoing unilateral open inguinal
herniorrhaphy.